IS Pharma


IS Pharma was formed when Aim-quoted Maelor acquired Speciality European Pharma International for an initial 9.25m, with the possibility of its increasing to 14.25m over a five year period. SEP's main product is Haemopressin, which is used to treat uncontrolled bleeding from oesophageal varices. The company also supplies a range of hospital medicines aimed at niche markets which are of little interest to the major pharmaceutical companies. IS Pharma (Maelor) joined Aim on 21 November 1997 via a placing at 88p a share - equivalent to 616p post-consolidation. On 22 April 2008 seven shares were consolidated into one new share.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds